BIOGEN INC. — Director's Dealing 2022

Oct 28, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOGEN INC. (BIIB)
CIK: 0000875045
Period of Report: 2022-10-27

Reporting Person: ALEXANDER SUSAN H (EVP Chief Legal Off & Corp Sec)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-10-27	Common Stock	S	5532	$280.70	Disposed	39396	Direct

Footnotes

F1: Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.